In March 2025, the company announced new programs for the immediate-to-shopper featuring of its Wegovy weight loss drug. The company proven a whole new pharmacy, called NovoCare, which might charge prospects $499 per month for access to the drug, less than 50 percent the expense of the drug by other pharmaceutical distribution networks.[fifty three